IQVIA (NYSE:IQV) Stock Acquired Sen. Markwayne Mullin

Senator Markwayne Mullin (R-Oklahoma) recently bought shares of IQVIA Holdings Inc. (NYSE:IQV). In a filing disclosed on January 16th, the Senator disclosed that they had bought between $15,001 and $50,000 in IQVIA stock on December 29th.

Senator Markwayne Mullin also recently made the following trade(s):

• Purchased $15,001 – $50,000 in shares of Deere & Company (NYSE:DE) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Hilton Worldwide (NYSE:HLT) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of RTX (NYSE:RTX) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of CocaCola (NYSE:KO) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Elevance Health (NYSE:ELV) on 12/29/2025.
• Purchased $1,001 – $15,000 in shares of American Express (NYSE:AXP) on 12/29/2025.
• Purchased $100,001 – $250,000 in shares of Amazon.com (NASDAQ:AMZN) on 12/29/2025.
• Purchased $50,001 – $100,000 in shares of JPMorgan Chase & Co. (NYSE:JPM) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of The Goldman Sachs Group (NYSE:GS) on 12/29/2025.
• Purchased $15,001 – $50,000 in shares of Boston Scientific (NYSE:BSX) on 12/29/2025.

IQVIA Stock Performance

IQV traded down $3.25 on Friday, hitting $238.03. 1,350,702 shares of the company traded hands, compared to its average volume of 1,068,363. The company has a 50 day moving average of $227.30 and a 200-day moving average of $203.34. IQVIA Holdings Inc. has a 12-month low of $134.65 and a 12-month high of $247.04. The stock has a market capitalization of $40.54 billion, a PE ratio of 32.65, a PEG ratio of 2.42 and a beta of 1.36. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 2.03.

IQVIA (NYSE:IQV) last released its earnings results on Tuesday, October 28th. The medical research company reported $3.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.98 by $0.02. The business had revenue of $4.10 billion for the quarter, compared to analyst estimates of $4.07 billion. IQVIA had a return on equity of 30.70% and a net margin of 8.07%.The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.84 earnings per share. IQVIA has set its FY 2025 guidance at 11.850-11.950 EPS. Sell-side analysts anticipate that IQVIA Holdings Inc. will post 10.84 earnings per share for the current year.

Insider Transactions at IQVIA

In other IQVIA news, insider Eric Sherbet sold 4,000 shares of the company’s stock in a transaction dated Wednesday, October 29th. The shares were sold at an average price of $219.70, for a total value of $878,800.00. Following the transaction, the insider directly owned 27,108 shares in the company, valued at approximately $5,955,627.60. This represents a 12.86% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently issued reports on IQV. TD Cowen downgraded IQVIA from a “buy” rating to a “hold” rating and increased their target price for the stock from $206.00 to $215.00 in a research note on Monday, November 3rd. Hsbc Global Res upgraded IQVIA from a “hold” rating to a “strong-buy” rating in a research report on Thursday, October 9th. Weiss Ratings restated a “hold (c)” rating on shares of IQVIA in a research report on Wednesday, October 8th. Wall Street Zen downgraded shares of IQVIA from a “buy” rating to a “hold” rating in a report on Saturday. Finally, Cowen downgraded shares of IQVIA from a “buy” rating to a “hold” rating in a report on Monday, November 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $249.19.

Institutional Trading of IQVIA

Several large investors have recently modified their holdings of IQV. Perigon Wealth Management LLC raised its position in shares of IQVIA by 4.0% during the 4th quarter. Perigon Wealth Management LLC now owns 2,807 shares of the medical research company’s stock worth $633,000 after purchasing an additional 107 shares during the last quarter. Aberdeen Group plc raised its holdings in shares of IQVIA by 39.6% in the fourth quarter. Aberdeen Group plc now owns 192,696 shares of the medical research company’s stock worth $43,436,000 after acquiring an additional 54,703 shares during the last quarter. Earned Wealth Advisors LLC lifted its position in shares of IQVIA by 19.0% in the fourth quarter. Earned Wealth Advisors LLC now owns 1,572 shares of the medical research company’s stock valued at $354,000 after acquiring an additional 251 shares in the last quarter. HF Advisory Group LLC boosted its stake in shares of IQVIA by 1,791.6% during the fourth quarter. HF Advisory Group LLC now owns 154,618 shares of the medical research company’s stock valued at $34,852,000 after acquiring an additional 146,444 shares during the last quarter. Finally, Blue Trust Inc. increased its position in IQVIA by 24.3% during the 4th quarter. Blue Trust Inc. now owns 537 shares of the medical research company’s stock worth $121,000 after purchasing an additional 105 shares in the last quarter. 89.62% of the stock is currently owned by institutional investors and hedge funds.

About Senator Mullin

Markwayne Mullin (Republican Party) is a member of the U.S. Senate from Oklahoma. He assumed office on January 11, 2023. His current term ends on January 3, 2027. Mullin (Republican Party) ran in a special election to the U.S. Senate to represent Oklahoma. He won in the special general election on November 8, 2022. Mullin is a member of the Cherokee Nation and one of four Native American members of the 116th Congress. At the age of 20, Mullin took over his father’s plumbing business. He is also a former professional mixed martial artist. Markwayne Mullin graduated from Stilwell High School. Mullin earned an associate degree in construction technology from Oklahoma State University Institute of Technology. His career experience includes owning and founding multiple businesses.

IQVIA Company Profile

IQVIA (NYSE: IQV) is a global provider of advanced analytics, technology solutions and contract research services to the life sciences industry. The company combines clinical research capabilities with large-scale health data and analytics to support drug development, regulatory reporting, commercial strategy and real?world evidence generation. IQVIA traces its current form to the combination of Quintiles and IMS Health announced in 2016 and subsequently rebranded as IQVIA, bringing together long-established clinical research operations and extensive healthcare information assets.

IQVIA’s principal activities include outsourced clinical development services (acting as a contract research organization for phases I–IV), real?world evidence and observational research, regulatory and safety services, and a suite of technology platforms that enable data integration, analytics and operational management.